These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 15318008)

  • 1. Impact of the meningococcal C conjugate vaccine in Spain: an epidemiological and microbiological decision.
    Cano R; Larrauri A; Mateo S; Alcalá B; Salcedo C; Vázquez JA
    Euro Surveill; 2004 Jul; 9(7):11-5. PubMed ID: 15318008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the meningococcal C conjugate vaccine in Spain: an epidemiological and microbiological decision.
    Cano R; Larrauri A; Mateo S; Alcalá B; Salcedo C; Vázquez JA
    Euro Surveill; 2004 Jul; 9(7):5-6. PubMed ID: 29183488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meningococcal disease in catalonia 1 year after mass vaccination campaign with meningococcal group C polysaccharide vaccine.
    Cardeñosa N; Domínguez A; Martínez A; Alvarez J; Pañella H; Godoy P; Minguell S; Camps N; Vázquez JA;
    Infection; 2003 Dec; 31(6):392-7. PubMed ID: 14735381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of vaccination during an epidemic of serogroup C meningococcal disease in Salvador, Brazil.
    Cardoso CW; Pinto LL; Reis MG; Flannery B; Reis JN
    Vaccine; 2012 Aug; 30(37):5541-6. PubMed ID: 22749604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evolution of meningococcal infection among infant population in the autonomous community of Valencia (1996-2000). Effectiveness of A+C meningococcal vaccination].
    Goicoechea Sáez M; Fullana Montoro AM; Momparler Carrasco P; Redondo Gallego MJ; Brines Solanes J; Bueno Cañigral FJ
    Rev Esp Salud Publica; 2003; 77(1):125-42. PubMed ID: 12696392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economics of an adolescent meningococcal conjugate vaccination catch-up campaign in the United States.
    Ortega-Sanchez IR; Meltzer MI; Shepard C; Zell E; Messonnier ML; Bilukha O; Zhang X; Stephens DS; Messonnier NE;
    Clin Infect Dis; 2008 Jan; 46(1):1-13. PubMed ID: 18171206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meningococcal serogroup C conjugate vaccination in England and Wales: coverage and initial impact of the campaign.
    Trotter CL; Ramsay ME; Kaczmarski EB
    Commun Dis Public Health; 2002 Sep; 5(3):220-5. PubMed ID: 12434692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in meningococcal C epidemiology and vaccine effectiveness after vaccine introduction and schedule modification.
    Garrido-Estepa M; León-Gómez I; Herruzo R; Cano R
    Vaccine; 2014 May; 32(22):2604-9. PubMed ID: 24662700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact and effectiveness of meningococcal C conjugate vaccine following its introduction in Spain.
    Larrauri A; Cano R; García M; Mateo Sd
    Vaccine; 2005 Jul; 23(32):4097-100. PubMed ID: 15908059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Paediatric meningococcal meningitis in France: ACTIV/GPIP network results].
    Levy C; Taha MK; Bingen E; Cohen R;
    Arch Pediatr; 2012 Sep; 19 Suppl 2():S49-54. PubMed ID: 22883366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiologic investigation and targeted vaccination initiative in response to an outbreak of meningococcal disease among illicit drug users in Brooklyn, New York.
    Weiss D; Stern EJ; Zimmerman C; Bregman B; Yeung A; Das D; Dentinger CM; Marx MA; Kornblum J; Lee L; Halse TA; Mayer LW; Hatcher CP; Theodore MJ; Schmink S; Harcourt BH; Zucker JR; Layton M; Clark TA;
    Clin Infect Dis; 2009 Apr; 48(7):894-901. PubMed ID: 19231975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Meningococcal disease. The situation in Spain in the 1998-1999 period].
    Cano Portero R; García Delgado C; de Mateo Ontañón S
    Rev Esp Salud Publica; 2000; 74(4):369-75. PubMed ID: 11031845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effectiveness of an immunization campaign with group A and C meningococcal polysaccharide vaccine in controlling an outbreak of group C meningococcal disease].
    Gong J; Li CY; Dong BQ; Huang JZ; Quan Y; Lu WZ; Luo CH; Mao WC; Liao HZ; Fang JS; Cui XL; Xie GL; Wu XH; Lan RW
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jun; 29(6):552-5. PubMed ID: 19040035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of a vaccination programme for an epidemic of meningococcal B in New Zealand.
    Arnold R; Galloway Y; McNicholas A; O'Hallahan J
    Vaccine; 2011 Sep; 29(40):7100-6. PubMed ID: 21803101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serogroup A meningococcal conjugate vaccine coverage after the first national mass immunization campaign-Burkina Faso, 2011.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Dec; 61(50):1022-4. PubMed ID: 23254256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dramatic decline of serogroup C meningococcal disease in Catalonia (Spain) after a mass vaccination campaign with meningococcal C conjugated vaccine.
    Salleras L; Domínguez A; Cardeñosa N
    Vaccine; 2003 Jan; 21(7-8):729-33. PubMed ID: 12531350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing epidemiology of meningococcal invasive disease in the Czech republic caused by new clone Neisseria meningitidis C:2a:P1.2(P1.5), ET-15/37.
    Krizova P; Musilek M
    Cent Eur J Public Health; 1995 Nov; 3(4):189-94. PubMed ID: 8903519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evolution of meningococcal disease in the community of Madrid. Effectiveness of antimeningococcal A+C vaccination].
    Gutiérrez Rodríguez MA; Ramírez Fernández R; García Gutiérrez J; Moreno Civantos A; Hernando García M; Arce Arnáez A; Sendra Gutiérrez JM; Bueno Vallejos R
    Rev Esp Salud Publica; 2000; 74(4):397-403. PubMed ID: 11031849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of mass vaccination with polysaccharide conjugate vaccine against serogroup C meningococcal disease in Spain.
    Salleras L; Domínguez A; Cardeñosa N
    Vaccine; 2003 Jan; 21(7-8):725-8. PubMed ID: 12531349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbiological and epidemiological investigation of the Neisseria meningitidis serogroup A epidemic in Niger in 2009: last wave before the introduction of the serogroup A meningococcal conjugate vaccine?
    Collard JM; Maman Z; Abani A; Mainasara HB; Djibo S; Yacouba H; Maitournam R; Sidikou F; Nicolas P; Rocourt J; Jusot JF
    Epidemiol Infect; 2011 Nov; 139(11):1656-60. PubMed ID: 21251346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.